Table 5.
Bacteria species detected in studies conducted on clinical isolates.
| Bacteria Species | Number of Studies | Number of Studies (%) |
|---|---|---|
| Multiple bacteria * | 3 | 4.55% |
| Staphylococcus aureus | 3 | 4.55% |
| Pseudomonas aeruginosa | 3 | 4.55% |
| Klebsiella Pneumoniae | 16 | 24.24% |
| Gram-negative spp. ** | 6 | 9.09% |
| Enterobacterales spp. | 12 | 18.18% |
| Enterobacteriaceae spp. | 19 | 28.79% |
| ENT *** | 12 + 19 | 46.97% |
| Escherichia coli | 6 | 9.09% |
| Acinetobacter baumannii | 3 | 4.55% |
| Brucella spp. | 1 | 1.52% |
| Enterococcus Faecium | 1 | 1.52% |
| Gram-positive spp. ** | 1 | 1.52% |
| Enterobacter spp. | 1 | 1.52% |
Description of the bacteria isolated from 66 studies on clinical isolates tested with plazomicin and included in the review. Notes: * Bacteria isolated by screening samples; ** data not available; *** Enterobacterales summed to Enterobacteriaceae.